Publications

Export 56 results:
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is S.M. Blower  [Clear All Filters]
2011
Gerberry, DJ, Blower SM.  2011.  Could we - should we - calculate a risk exposure score for an HIV-negative individual in a serodiscordant couple? AIDS. 25:1119-21.
2009
Wagner, BG, Blower SM.  2009.  Voluntary universal testing and treatment is unlikely to lead to HIV elimination: a modeling analysis. Nature Precedings. Abstract  Download: NOelimination2009-10-29.pdf (274.49 KB)
2008
Wilson, DP, Coplan PM, Wainberg MA, Blower SM.  2008.  The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. PNAS. 105(28) Abstract  Download: Full Text (756.56 KB); Supplemental Material (1.9 MB)
2007
Blower, SM, Vardavas R.  2007.  The Emergence of HIV Transmitted Resistance in Botswana: ‘‘When Will the WHO Detection Threshold Be Exceeded?’’ PLoS One.  Download: plosone_botswana_2007.pdf (216.69 KB)
2006
Wilson, DP, Kahn J, Blower SM.  2006.  Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. PNAS. 103:14228-33. Abstract
Wilson, DP, Blower SM.  2006.  Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility. PLoS Med. 3:e160.
2005
Smith, RJ, Bodine EN, Wilson DP, Blower SM.  2005.  Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS. 19:413-21. Abstract
Wilson, DP, Bodine EN, Smith RJ, Blower SM.  2005.  Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'. AIDS. 19:2044-6.
Wilson, DP, Blower SM.  2005.  Allocating antiretrovirals in South Africa: using modeling to determine treatment equity. PLoS Med. 2:e155;authorreplye186.
Wilson, DP, Blower SM.  2005.  Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med. 2:e50. Abstract
Blower, SM, Bodine EN, Grovit-Ferbas K.  2005.  Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of subtypes. Curr Drug Targets Infect Disord. 5:179-92. Abstract
2004
Crespi, CM, Cumberland WG, Blower SM.  2004.  A within-host model of Herpes Simplex Virus. Proceedings of the American Statistical Association, Bayesian Statistical Science
Smith, RJ, Blower SM.  2004.  Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis. 4:636-9. Abstract
Wilson, DP, Blower SM.  2004.  Microbicides: anti-HIV efficacy and ethics. Science. 306:1890;authorreply1890.
2003
Gershengorn, HB, Darby G, Blower SM.  2003.  Predicting the emergence of drug-resistant HSV-2: new predictions. BMC Infect Dis. 3:1. Abstract
Blower, SM, Moss RB, Fernandez-Cruz E.  2003.  Calculating the potential epidemic-level impact of therapeutic vaccination on the San Francisco HIV epidemic. AIDScience. 3
Blower, SM, Aschenbach AN, Kahn JO.  2003.  Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis. 3:10-1.
2002
Blower, SM, Daley CL.  2002.  Problems and solutions for the Stop TB partnership. Lancet Infect Dis. 2:374-6. Abstract
Velasco-Hernandez, JX, Gershengorn HB, Blower SM.  2002.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2:487-93. Abstract
2001
Porco, TC, Small PM, Blower SM.  2001.  Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. J Acquir Immune Defic Syndr. 28:437-44. Abstract
Ziv, E, Daley CL, Blower SM.  2001.  Early therapy for latent tuberculosis infection. Am J Epidemiol. 153:381-5. Abstract
Blower, SM, Koelle K, Kirschner DE, Mills J.  2001.  Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety. Proc Natl Acad Sci U S A. 98:3618-23. Abstract
Blower, SM, Aschenbach AN, Gershengorn HB, Kahn JO.  2001.  Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med. 7:1016-20. Abstract
2000
Gershengorn, HB, Blower SM.  2000.  The Impact of antivirals and emergence of drug resistance: HSV-2 epidemic control. AIDS Patient Care STDS. 14:133-42. Abstract
Lietman, T, Blower SM.  2000.  Potential impact of tuberculosis vaccines as epidemic control agents. Clin Infect Dis. 30 Suppl 3:S316-22. Abstract